Community pharmacists: take advantage of fully funded postgraduate courses

Community pharmacists: take advantage of fully funded postgraduate courses

May 31, 2019

Community pharmacists are reminded of a number of postgraduate courses, funded by the Pharmacy Integration Fund until March 2020.
Applications are open now, so act now to secure your place. A summary of the courses on offer, closing dates and contact details can be found here.

To be eligible for tuition fee funding, you must be a community pharmacist practising in a patient facing role for at least 15 hours a week (0.4 Whole Time Equivalent, which is roughly two days a week).
The Pharmacy Integration Fund will fund eligible pharmacists to complete Postgraduate training modules at designated universities, subject to funding availability. Learners can choose from a range of courses and modules to develop their clinical practice. The Fund will cover the tuition fees for chosen modules, up to a maximum of 60 credits in a year (this can be for a Postgraduate Certificate, Diploma or CPD for revalidation).

Health Education England has confirmed that as part of the Pharmacy Integration Fund, community pharmacists who have completed 60 credits towards a Postgraduate Certificate can apply for up to a further 60 credits to work towards a fully funded Postgraduate Diploma in Clinical Pharmacy.

All courses are designed with flexibility in mind, allowing you to study at work or in your own time, with minimal or no face to face time. You can apply to any university regardless of location.

For further information on applying, modules on offer, study requirements and deadline dates see the individual provider sites. Participating Universities will guide you through the registration process and help you select the modules that are best for you, based on your career stage and aspirations.

More information on the Pharmacy Integration Fund can be found on and PSNC’s Post-Registration Training for Community Pharmacists page.

More Latest News >

Help the fight against COVID-19

Help the fight against COVID-19 The PRINCIPLE trial aims to find treatments that reduce hospital admission and improve symptoms for...

Espranor packaging changing

From June 2020 Ethypharm will be changing Espranor packaging for both the 2mg and 8mg dose strengths from a pack...

Easter Opening Hours

Whilst we understand the rationale behind the decision to direct pharmacies to open, the LPC is very disappointed with the...